On June 20, 2011
Valeant, an Aggressive Buyer of Drug Companies, Acquires Its Way to Mediocrity
Could Valeant be growing up, and in so doing turning into just another boring old drug company? Its numbers suggest that’s exactly what’s happening: It’s acquiring its way to mediocrity.
No tags for this post.
0 Comments